Barriers preclude rural women from breast cancer screening

October 25, 2004

While breast cancer screening in rural America remains underutilized, barriers to screening mammography in poor, rural areas are marked by significant racial disparities, according to a new study. These barriers include poor knowledge about breast cancer and screening, difficulty accessing facilities, and lack of encouragement and funds to get screened. These factors are particularly striking among Native Americans. The study will be published in the December 1, 2004 issue of CANCER, a peer-reviewed journal of the American Cancer Society. A free abstract of this study will be available via the CANCER News Room (http://www.interscience.wiley.com/cancer-newsroom) upon online publication.

Recent advances in breast cancer screening and treatments have led to an important reduction in death rates from breast cancer in American women in recent years. While early detection has been shown to reduce breast cancer deaths, its impact on mortality rates across the nation depends on large numbers of women getting screened. Current screening rates approaches 40 percent of eligible women, far less than the national goal of 80 percent. Women in rural America, particularly from minority groups, have even lower utilization rates.

In 1996 an intervention designed to increase screening among low-income women called the Robeson County Outreach Screening and Education (ROSE) Project began in North Carolina. This community-based education project targeted Caucasian, African-American, and Native American women over 40 years old. In this study Electra D. Paskett, Ph.D., Director of Center for Population Health and Health Disparities at the Ohio State University Comprehensive Cancer Center, and her colleagues characterized and compared the baseline knowledge, beliefs, and behaviors about breast cancer screening among 897 women enrolled in this project.

African-American women and, to a significantly greater extent, Native American women had less information and more inaccurate beliefs about screening compared to Caucasian women. For example, 43 percent of women did not identify "mammogram" as a breast cancer screening test, with a significantly larger proportion of Caucasians (70 percent) able to do so. African-Americans reported less self-perceived risk of breast cancer than other groups while Native Americans perceived greater risk than other groups.

Overall, pain, embarrassment, and lack of time were major reasons for women not electing screening, while lack of knowledge about testing options and recommendations or risk factors further promoted poor utilization. Moreover, despite most women having annual checkups by a doctor, more than two-thirds reported no encouragement or recommendation for a mammogram by their doctor.

The authors conclude that "the results point to groups of women in need of interventions to change beliefs, reduce barriers, and improve knowledge in order to improve adherence to screening guidelines." They add, "low-income women are in need of encouragement to be screened and to be made aware of opportunities to obtain low-cost mammography."
-end-
Article: "Racial Differences in Knowledge, Attitudes and Cancer Screening Practices among a Triracial Rural Population," Electra D. Paskett, Cathy Tatum, Julia Rushing, Robert Michielutte, Ronny Bell, Kristie Long Foley, Marisa Bittoni, Stephanie Dickinson, CANCER; Published Online: October 25, 2004 (DOI: 10.1002/cncr.20671); Print Issue Date: December 1, 2004.

Wiley

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.